论文部分内容阅读
目的分析临床针对扩心病患者选择依那普利加美托洛尔治疗的效果。方法选择2015年10月—2016年10月在驻马店市第一人民医院接受治疗的扩心病患者84例参与研究,随机平均分成2组,对照组对患者实施基础对症治疗,观察组在基础对症治疗之外联合依那普利、美托洛尔治疗,比较两组治疗效果。结果观察组治疗后总有效率为90.48%,对照组总有效率为71.43%;观察组治疗后舒张压、收缩压、心率、LVEF均优于对照组;观察组治疗后6 min步行距离为(507.6±38.4)m,对照组6 min步行距离为(401.3±35.2)m。结论依那普利加美托洛尔治疗扩心病能够更有效改善患者心率以及血压水平,提升治疗效果,值得推广。
Objective To analyze the clinical effect of enalapril plus metoprolol in patients with heart disease. Methods From October 2015 to October 2016, 84 cases of patients with heart disease who were treated in the First People’s Hospital of Zhumadian City were enrolled and randomly divided into two groups. The control group was given basic symptomatic treatment and the observation group was treated with basic symptomatic treatment In addition to enalapril and metoprolol, the treatment effects were compared between the two groups. Results After treatment, the total effective rate was 90.48% in the observation group and 71.43% in the control group. The diastolic blood pressure, systolic blood pressure, heart rate and LVEF in the observation group were better than those in the control group. The walking distance at 6 minutes after the observation group was ( 507.6 ± 38.4) m, while the control group had a walking distance of (401.3 ± 35.2) m at 6 min. Conclusion Enalapril plus metoprolol treatment of heart disease can be more effective in improving heart rate and blood pressure in patients with elevated therapeutic effect, it is worth promoting.